Director/PDMR Shareholding

11 September 2015

RIGHTMOVE PLC

DIRECTOR/PDMR SHAREHOLDING

Rightmove plc (the “Company”) has received the following notifications today from, Nick McKittrick, Chief Executive Officer and Peter Brooks-Johnson, Chief Operating Officer:

Nick McKittrick confirmed that, today, he exercised his right to acquire:

• 51,178 performance shares awarded at nil cost in May 2011 ahead of the last exercise date of 3 March 2016 which includes rolled up dividend payments of 1,889 shares. Nick subsequently sold all the ordinary shares of 1p each in the Company (“ordinary shares”) received at an average price of 3739.4373p per share.
• 15,184 deferred shares awarded at nil cost in March 2013 in respect of his 2012 financial year bonus ahead of the last exercise date of 7 March 2016. Nick subsequently sold all the ordinary shares received at an average price of 3734.2624p per share.
• 37,703 performance shares awarded at nil cost in March 2012; these vested in March 2015 and represent 92.35% vesting of the original 39,303 award, together with rolled up dividend payments of 1,406 shares. He subsequently sold all the ordinary shares received at an average price of 3739.4373p per share.
• 114,165 unapproved executive share options awarded in March 2010 at an exercise price of 666p. He subsequently sold all the ordinary shares received at an average price of 3739.4373p per share.

The number of ordinary shares sold in total represented 0.206% of the ordinary shares in issue (less shares held in treasury) prior to such sale.

Following these transactions, the beneficial shareholding of Nick McKittrick is 141,027 ordinary shares representing 0.147% of the ordinary shares in issue (excluding shares held in treasury). He also holds executive and Sharesave options over 280,905 ordinary shares, deferred share awards over 16,770 ordinary shares and 91,618 performance shares.

Peter Brooks-Johnson confirmed that, today, he exercised his right to acquire 24,605 performance shares awarded at nil cost in May 2011 ahead of the last exercise date of 3 March 2016. These include rolled up dividend payments of 908 shares. Peter  has subsequently sold 11,588 of the ordinary shares received in order to satisfy the taxation liability arising thereon, at an average price of 3734.2624p per share and retained the balance being 13,017 ordinary shares. The number of ordinary shares sold represented 0.012% of the ordinary shares in issue (less shares held in treasury) prior to such sale.

Peter Brooks-Johnson also confirmed that today, he exercised his right to acquire 2,439 approved executive share options awarded in March 2006 at an exercise price of 410p ahead of the last exercise date of 13 March 2016. Peter has subsequently sold 275 ordinary shares received at an average price of 3739.4373p per share and retained the balance being 2164. The number of ordinary shares sold represented 0.000% or the ordinary shares in issue (less shares held in treasury) prior to such sale.

Following these transactions, the beneficial shareholding of Peter Brooks-Johnson is 37,664 ordinary shares representing 0.039% of the ordinary shares in issue (excluding shares held in treasury). He also holds executive and Sharesave options over 267,989 ordinary shares, deferred share awards over 13,238 ordinary shares and 99,841 performance shares.

This announcement is made under the UKLA’s Disclosure and Transparency Rule 3.1.4R.

Ends

Name and contact number for queries:

Jenny Warburton 0207 087 0739